Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1Neoplasms 1Melanoma 1Hypotension 1Carcinoma, Renal Cell 1

Interventions

Fentanyl 23Analgesia 22Morphine 19Acupuncture Therapy 18Zoledronic Acid 15Oxycodone 14Acetaminophen 14Ketamine 13Radiotherapy 12Therapeutics 11Methadone 11Lidocaine 11nabiximols 10Ibandronic Acid 10Hydromorphone 10Bupivacaine 10Surveys and Questionnaires 8Ropivacaine 8Psychiatric Rehabilitation 7Early Intervention, Educational 7Saline Solution 6Music Therapy 6Cryotherapy 6Cryosurgery 6Yoga 5Water 5Tapentadol 5Pregabalin 5Methods 5Massage 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pain × imisopasem manganese × Clear all
NCT00101621 2006-02-09

Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain

MetaPhore Pharmaceuticals

Phase 2 Terminated
24 enrolled

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡